Effects of Curcuminoids and Surfactant-Formulated Curcumin on Chemo-Resistant Colorectal Cancer

Area of Science:

• Oncology
• Pharmacology
• Immunology

Background:

• Colorectal cancer (CRC) is a significant cause of cancer mortality.
• Chronic gut inflammation is a known risk factor for CRC development.
• Curcumin, a major component of turmeric, exhibits anticancer properties but suffers from poor bioavailability.

Purpose of the Study:

• To evaluate the chemopreventive efficacy of a novel surfactant-formulated curcumin (CuminUP60) against chemo-resistant colorectal cancer.
• To investigate the effects of CuminUP60 on chemo-resistant colorectal cancer cell lines.
• To assess the impact of CuminUP60 on immune responses relevant to gut malignancies.

Main Methods:

• Utilized a novel surfactant-formulated curcumin (CuminUP60) water solution.
• Assessed antiproliferative effects on the chemo-resistant SW-480 colorectal cancer cell line.
• Analyzed apoptosis induction, cell cycle arrest (G2/M phase), cyclin B1 expression, and Th17 cell differentiation.

Main Results:

• CuminUP60 demonstrated significant dose- and time-dependent antiproliferative effects on SW-480 cells.
• The formulation induced early apoptosis and G2/M cell cycle arrest by upregulating cyclin B1.
• CuminUP60 inhibited Th17 cell differentiation, suggesting immune-modulatory effects.

Conclusions:

• Surfactant-formulated curcumin (CuminUP60) shows potent activity against chemo-resistant colorectal cancer cells.
• The formulation enhances curcumin bioavailability and exhibits anti-cancer effects through apoptosis and cell cycle arrest.
• CuminUP60 may offer a potential therapeutic strategy for managing chemo-resistant colorectal cancer and modulating the immune response.